glp 1 eating disorder Tips for prescribing GLP-1s in patients with disorders GLP-1 Therapy Chicago & Northbrook
Description
Secondary outcomes included changes in MDS-UPDRS when on dopamine-based medication, as well as off-and-on state analysis of timed sit-stand-walk tests and scores from a battery of neuropsychological exams
(2018) Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist
How should it be stored
Heart disease
The cost is also much less expensive than the injectable, potentially making the therapy accessible to more people who would not qualify for insurance to cover it
